Jason Bhan

MD, Co-Founder & Chief Medical Officer
Medivo

Jason Bhan, MD, is a Family Physician and serves as the Chief Medical Officer at Medivo. He is regarded as a national expert in the applications of technology to healthcare and medicine, a topic on which he speaks regularly at institutions and conferences, such as Health 2.0, mHealth, New York’s eHealth Collaborative, and Health Datapalooza. He also has done extensive strategy consulting with pharmaceutical companies.

From 2007-2010, Dr. Bhan worked with Clinovations and managed several large hospital system EHR implementations, outcomes measurements and data analysis. Dr. Bhan obtained his Doctor of Medicine at the University of Miami School of Medicine and he is board certified in Family Medicine.

Check out the incredible speaker line-up to see who will be joining Jason.

Download The Latest Agenda

Selecting the Channel Best Suited to Customer Engagement

Wednesday, January 4th, 2017

12:15 Interactive Roundtable Discussions

#1 Evolution of the U.S. Pharma Commercial Model in the New Healthcare Environment
Paul Darling, Principal, ZS Associates

#2 Mapping the Customer Journey to Create Positive Experiences that Engage Customers
Sandra Velez, Content Marketing Lead, Merck

#3 IMS Health Topic TBD
Justin Hawver, Sr Managed Services Consultant, IMS Health
Mark Klapper, Engagement Manager, IMS Health

#4 Getting the Most Out of Content and Inbound Marketing
Kevin Watson, Multichannel Marketing Engagement Lead, UCB

#5 Critical Decisions and Activities to Build a Commercial Infrastructure: Small Biopharma Perspective
Katie MacFarlane, Chief Commercial Officer, Agile Therapeutics

#6 Unlocking the Power of Clinical Diagnostics
Jason Bhan, Co-Founder, & Chief Medical Officer, Medivo

#7 Adobe Digital Index: state of digital healthcare
Tamara Gaffney, Adobe

#8 Specialty Care Data – Analytics
Ed Stelmack, AstraZeneca

PharmaForce 2016 (past event)

Jason Bhan

Selecting the Channel Best Suited to Customer Engagement

12:15 Interactive Roundtable Discussions

16:40 Addressing Pharma Brand Challenges with Clinical Diagnostics